Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Hemangioma, Capillary 3Vascular Malformations 1Recurrence 1Port-Wine Stain 1Papilloma 1Keratosis, Actinic 1Hemangioma 1

Interventions

Timolol 7Propranolol 6Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hemangioma, Capillary × Lasers, Dye × Clear all
NCT01873131 2023-11-02

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Massachusetts General Hospital

Phase NA Recruiting
126 enrolled

Hemangioma, Hemangioma, Capillary

NCT00573729 2022-10-20

Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths

University of California, Irvine

Phase 1 Completed
56 enrolled

Hemangioma, Capillary, Vascular Malformations

NCT00365118 2008-06-03

Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser

Bispebjerg Hospital

Phase NA Completed

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡